← Back to headlines
GENESIS Pharma Expands Partnership with Alnylam Pharmaceuticals into Scandinavia
GENESIS Pharma is expanding its collaboration with Alnylam Pharmaceuticals, adding four Scandinavian markets—Denmark, Finland, Norway, and Sweden—to the thirteen markets in Southeast Europe already covered by their partnership.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
